RCS - Intnl. Biotechnology - Investor Presentation

International Biotechnology Trust

29/10/2024 11:32

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241029:nRSc0723Ka&default-theme=true

RNS Number : 0723K  Intl. Biotechnology Trust PLC  29 October 2024

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

 

Investor Presentation

 

International Biotechnology Trust plc is pleased to announce that Ailsa Craig
and Marek Poszepczynski will provide a live presentation on the Company's
results for the year ended 31 August 2024 via the Investor Meet Company
platform on Tuesday 5 November 2024 at 14:00 pm GMT.

 

The presentation is open to all existing and potential investors. Questions
can be submitted pre-event via your Investor Meet Company dashboard before the
meeting or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and add to
meet INTERNATIONAL BIOTECHNOLOGY TRUST PLC via:

https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor
(https://www.investormeetcompany.com/international-biotechnology-trust-plc/register-investor)

 

Investors who already follow INTERNATIONAL BIOTECHNOLOGY TRUST PLC on the
Investor Meet Company platform will automatically be invited.

 

ENDS

 

Enquiries:

 

 Schroder Investment Management Limited

 Charlotte Banks (Press)                                                   020 7658 6000

 Kirsty Preston

 Kerry Higgins (Company Secretary)                                         020 7658 6000

 Kaso Legg Communications (Financial PR)

 Charles Gorman                                                            IBT@kl-communications.com

 Henry Taylor

 Effie Aye Maung Hider

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUKOARSRURUAA